Kelun-Biotech Receives a Clinical Trial Notice for Its First Dual-payload ADC SKB565

CHENGDU, China, July 27, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

(“Kelun-Biotech” or the “Company”, 6990.HK) today announced that it has received a clinical trial notice from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) approving the Investigational New Drug (IND) application for its novel dual-payload ADC drug, SKB565, for […] ...